These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21532323)

  • 21. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
    Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
    Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.
    Bishburg E; Bishburg K
    Int J Antimicrob Agents; 2009 Nov; 34(5):395-401. PubMed ID: 19665876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
    Huang V; Cheung CM; Kaatz GW; Rybak MJ
    Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of Staphylococcus aureus.
    Deurenberg RH; Stobberingh EE
    Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Livestock associated methicillin-resistant Staphylococcus aureus (LaMRSA) isolated from lesions of pigs at necropsy in northwest Germany between 2004 and 2007.
    Meemken D; Blaha T; Tegeler R; Tenhagen BA; Guerra B; Hammerl JA; Hertwig S; Käsbohrer A; Appel B; Fetsch A
    Zoonoses Public Health; 2010 Dec; 57(7-8):e143-8. PubMed ID: 20042059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Children with atopic dermatitis appear less likely to be infected with community acquired methicillin-resistant Staphylococcus aureus: the San Diego experience.
    Matiz C; Tom WL; Eichenfield LF; Pong A; Friedlander SF
    Pediatr Dermatol; 2011; 28(1):6-11. PubMed ID: 21070347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.
    Skiest DJ; Brown K; Cooper TW; Hoffman-Roberts H; Mussa HR; Elliott AC
    J Infect; 2007 May; 54(5):427-34. PubMed ID: 17070598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current challenges in treating MRSA: what are the options?
    Ratnaraja NV; Hawkey PM
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):601-18. PubMed ID: 18847401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergency management of pediatric skin and soft tissue infections in the community-associated methicillin-resistant Staphylococcus aureus era.
    Mistry RD; Weisz K; Scott HF; Alpern ER
    Acad Emerg Med; 2010 Feb; 17(2):187-93. PubMed ID: 20370748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of octenidine dihydrochloride in meticillin-resistant Staphylococcus aureus decolonisation regimens: a literature review.
    Krishna BV; Gibb AP
    J Hosp Infect; 2010 Mar; 74(3):199-203. PubMed ID: 20060619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.
    Kruszewska D; Sahl HG; Bierbaum G; Pag U; Hynes SO; Ljungh A
    J Antimicrob Chemother; 2004 Sep; 54(3):648-53. PubMed ID: 15282239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections].
    Bernard P; Jarlier V; Santerre-Henriksen A
    Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
    J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
    Yin LY; Calhoun JH; Thomas TS; Wirtz ED
    J Antimicrob Chemother; 2009 Feb; 63(2):357-60. PubMed ID: 19060292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment with moxifloxacin of experimental aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Galani L; Pefanis A; Sakka V; Iliopoulos D; Donta I; Triantafyllidi H; Skiadas I; Karayiannakos P; Giamarellou H
    Int J Antimicrob Agents; 2009 Jan; 33(1):65-9. PubMed ID: 18818055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
    J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of AFN-1252, the First Staphylococcus-Specific Antibacterial Agent, in the Treatment of Acute Bacterial Skin and Skin Structure Infections, Including Those in Patients with Significant Comorbidities.
    Hafkin B; Kaplan N; Murphy B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1695-701. PubMed ID: 26711777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oxadiazole antibacterials.
    Janardhanan J; Chang M; Mobashery S
    Curr Opin Microbiol; 2016 Oct; 33():13-17. PubMed ID: 27239942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.